Guidance note on the development of vaccinia virus based vaccines against smallpox

July 2, 2002

Brussels, 01 July 2002

At the request of the European Commission, Enterprise DG, the Pharmaceuticals Unit, the EMEA and its Scientific Committee, the Committee for Proprietary Medicinal Products (CPMP) produced a guidance document Note for guidance on the development of vaccinia virus based vaccines against smallpox. This Note for Guidance will be updated as further experience is gained in the development and manufacture of second generation smallpox vaccines.

Guidance document note

Please login or register to read this article

Register to continue

Get a month's unlimited access to THE content online. Just register and complete your career summary.

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments